Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Format: Module
This module reviews features of skin and soft tissue infections among people who inject drugs, reviews risk factors for Hepatitis C (HCV) and HIV, describes prevention interventions for HCV and HIV, and discusses treatment approaches for HCV and HIV in patients with opioid use disorder.
Presenter(s):
Jeanette M. Tetrault, MD, FACP, FASAM, Professor of Medicine and Public Health, Yale School of Medicine
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Format: Webinar
This educational activity, presented by Dr. Phillip Coffin, explores the evolving landscape of methamphetamine use amidst the growing presence of fentanyl. Attendees will gain insights into current morbidity and mortality trends, the physiological mechanisms behind methamphetamine toxicity, and evidence-based interventions for managing methamphetamine use disorder (MeUD). Emphasis will be placed on comprehensive prevention, treatment strategies, and addressing the long-term cardiovascular and neuropsychiatric impacts associated with chronic use.
Presenter(s):
Phillip Coffin, MD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Nursing Contact Hours, Social Work CE Credit, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE)
Format: Webinar
Due to the opioid epidemic, over 2.5 million adults in the U.S. have opioid use disorder (OUD), yet only 25% of those who need treatment receive recommended medication for opioid use disorder (MOUD). Alongside the rising rates of OUD, there has been an increase in infectious diseases such as HIV, hepatitis B and C, endocarditis and skin and soft-tissue infections, particularly among people who inject drugs. These intertwining epidemics have not been sufficiently addressed, but MOUD — combined with appropriate substance use treatment supports and health care services — represents an opportunity to reduce risk and improve health outcomes.
Presenter(s):
Daniel Rosa, MD
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour